Jeroen Jansen, PhD, lead scientific advisor, Open-Source Value Project, Innovation and Value Initiative, discusses challenges with incorporating more novel concepts of value into value assessment.
Jeroen Jansen, PhD, lead scientific advisor, Open-Source Value Project, Innovation and Value Initiative, discusses challenges with incorporating more novel concepts of value into value assessment.
Transcript
What challenges are there with incorporating more novel concepts of value into value assessment?
That’s an interesting question. Traditionally, a lot of the value assessment is done in what’s called a cost-effectiveness analysis framework where we calculate the expected costs and the expected risks and benefits for the patients. But now, there’s a discussion like what novel elements need to be incorporated. For example, one of the novel elements is what’s called “value of hope,” which means that even if on the average, 2 interventions give you the same benefits, it might be that one of the interventions has more variation in how individual patients may respond versus the other intervention. It might be that certain patients prefer the intervention where you see more variation in response because they might be the lucky ones to respond much better than the simple average. That’s currently, for example, overlooked.
Another component, one of the other novel elements, is something that’s called insurance value, where we say currently, value assessment is all about how can we optimize treatment allocation given the budgets we have to work with. But, the value of an intervention goes beyond the individuals patients. For example, if we have a new efficacious treatment for example for Alzheimer, that benefits everyone of us that is potentially at risk for Alzheimer disease.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More